Disposition of Flavonoids via Recycling: Comparison of Intestinal versus Hepatic Disposition
Open Access
- 24 August 2005
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 33 (12), 1777-1784
- https://doi.org/10.1124/dmd.105.003673
Abstract
The purpose of this study was to compare intestinal versus hepatic disposition of six flavonoids to fully characterize their first-pass metabolism. The perfused rat intestinal model and microsomes prepared from rat liver, duodenum, jejunum, ileum, and colon were used. The results indicated that isoflavone (12.5 μM) glucuronidation was highly variable among different microsomes prepared from liver or intestine. Comparing to liver metabolism, the intestinal metabolism had higher Km values (>2-fold). Likewise, the hepatic intrinsic clearance (IC, or a ratio of Vmax/Km) values of isoflavones were generally higher than their intestinal IC values (200–2000% higher), except for prunetin, for which the jejunal IC value was 50% higher than its hepatic IC. When comparing intestinal metabolism, the results showed that intestinal metabolism rates and Vmax values of isoflavones were less when an additional A-ring electron-donating group was absent (i.e., daidzein and formononetin). In the rat perfusion model using the whole small intestine, genistein (10 μM) was well absorbed (77% or 352 nmol/120 min). The first-pass metabolism of genistein was extensive, with 40% of absorbed genistein excreted as conjugated metabolites into the intestinal lumen. In contrast, the bile excretion of genistein conjugates was much less (6.4% of absorbed genistein). In conclusion, intestinal glucuronidation is slower in isoflavones without an additional A-ring substitution. Perfusion studies suggest that intestine is the main organ for genistein glucuronide formation and excretion in rats and may serve as its main first-pass metabolism organ.Keywords
This publication has 16 references indexed in Scilit:
- Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 modelCancer Chemotherapy and Pharmacology, 2004
- Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II ConjugatesThe Journal of pharmacology and experimental therapeutics, 2004
- Disposition Mechanisms of Raloxifene in the Human Intestinal Caco-2 ModelThe Journal of pharmacology and experimental therapeutics, 2004
- Metabolism of Flavonoids via Enteric Recycling: Mechanistic Studies of Disposition of Apigenin in the Caco-2 Cell Culture ModelThe Journal of pharmacology and experimental therapeutics, 2003
- Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal DispositionThe Journal of pharmacology and experimental therapeutics, 2002
- Atypical kinetic profiles in drug metabolism reactions.Drug Metabolism and Disposition, 2002
- Dietary agents in cancer prevention: flavonoids and isoflavonoidsPharmacology & Therapeutics, 2001
- Distribution and Inducibility by 3-Methylcholanthrene of Family 1 UDP-Glucuronosyltransferases in the Rat Gastrointestinal TractArchives of Biochemistry and Biophysics, 2000
- LC-ESI-MS Study of the Flavonoid Glycoside Malonates of Red Clover (Trifolium pratense)Journal of Agricultural and Food Chemistry, 2000
- DIETARY PHYTOESTROGENSAnnual Review of Nutrition, 1997